Back to search

National and Kapodistrian University of Athens

Μελέτη του ομοδιμερισμού της πρωτεΐνης bri2

Abstract

dc:description

BRI2 is a protein involved in Familial British Dementia (FBD) and Familial Danish Dementia (FDD), since patients with those dementias bear mutations in the gene that encodes for BRI2. Both diseases are characterized by progressive dementia and result in death. FBD and FDD present striking neuropathological similarities with Alzhemer’s disease (AD). Among those similarities is the deposition of amyloid peptides in the brains of patients. In FBD/FDD the peptides are produced after the proteolytic processing of the mutated forms of BRI2. In AD the peptide deposited is Aβ, and is derived from the proteolytic processing of the Amyloid Precursor Protein (APP). BRI2 physiological role remains elusive. Ηowever, there are studies that attribute different functions to BRI2. For example, we showed previously that BRI2 interacts with APP and reduces its proteolysis, as well as Aβ production. In an attempt to approach the physiological role of BRI2, we examined the possibility that it homodimerizes. Two structural features in the primary structure of BRI2 led us to hypothesize that it could homodimerize. First, BRI2 contains in its transmembrane domain the GXXXG motif that has been implicated in the homodimerization of transmembrane proteins. In addition, BRI2 contains in its extracellular sequence one free cysteine residue 89 (C89) that could mediate the association of two BRI2 molecules through an intermolecular disulfide bond. Based on the above, we showed that in cell lines expressing two BRI2 proteins tagged with different epitope tags, two BRI2 molecules interact. In addition, we directly detected the homodimers in cells using the BiFC assay (Bimolecular Fluorescence Complementation). Endogenous BRI2 in mouse brain extracts also forms homodimers. Subsequently, the involvement of the GXXXG motif in BRI2 homodimerization was examined. Mutation of glycine to leucine residues, and immunoprecipitation experiments, indicated that mutation of the motif does not inhibit homodimerization. To investigate whether BRI2 homodimerizes with the involvement of disulfide bonds, we expressed BRI2 in cells and performed Western Blot analysis of the cell extracts under non-reducing conditions. Under these conditions, we detected monomers as well as homodimers in double the molecular weight of the monomer. Mutation of cysteine indicated that it is responsible for the formation of the intermolecular disulfide bonds formed between two BRI2 molecules. Apart from disulfide bonds non-covalent interactions were shown to participate in the homodimerization. To identify the responsible region for those interactions we created BRI2 constructs that bear certain deletions and a mutation in C89. Using the corresponding mutated proteins we showed that non-covalent interactions exist within the sequence after aminoacid 107. In addition, we showed that BRI2 homodimers are formed in the ER and that BRI2 exists at the cell surface as a homodimer. Finally, we showed that homodimerization is a prerequisite for BRI2 interaction with APP.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Τσαχάκη, Μαρία
  • Tsachaki, Maria

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/18808

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Τσαχάκη, Μαρία; Tsachaki, Maria. Μελέτη του ομοδιμερισμού της πρωτεΐνης bri2. National and Kapodistrian University of Athens, 2009. http://hdl.handle.net/10442/hedi/18808